Cargando…

First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study

BACKGROUND: Treatment of metastatic pancreatic adenocarcinoma (mPAC) relies on chemotherapeutic regimens. We investigated patterns of first-line and second-line treatment choices, their geographical variation between European countries, and alignment with current European recommendations. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taieb, Julien, Prager, Gerald W, Melisi, Davide, Westphalen, C Benedikt, D'Esquermes, Nathalie, Ferreras, Anabel, Carrato, Alfredo, Macarulla, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003396/ https://www.ncbi.nlm.nih.gov/pubmed/31958291 http://dx.doi.org/10.1136/esmoopen-2019-000587

Ejemplares similares

From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer
por: Martín, Andrés Muñoz, et al.
Publicado: (2018)

Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review
por: Arnold, D, et al.
Publicado: (2018)

Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe
por: Taieb, Julien, et al.
Publicado: (2023)

Maximising clinical benefit with adequate patient management beyond the second line in mCRC
por: Argiles, Guillem, et al.
Publicado: (2019)

Charting the role of the number line in mathematical development
por: LeFevre, Jo-Anne, et al.
Publicado: (2013)

A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid
por: Kieler, Markus, et al.
Publicado: (2019)

Safety and efficacy of nivolumab as a second line therapy in metastatic renal cell carcinoma: a retrospective chart review
por: Gamulin, Marija, et al.
Publicado: (2020)

Europe charts future for radioactive beams
Publicado: (2010)

Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice
por: Laquente, Berta, et al.
Publicado: (2020)

Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients
por: Merz, Valeria, et al.
Publicado: (2020)

FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
por: Zaanan, Aziz, et al.
Publicado: (2014)

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer
por: Macarulla, T, et al.
Publicado: (2015)

An Easy Way of Determining Corpuscular Values by the Use of a Line Chart
por: Swamy, T. V., et al.
Publicado: (1952)

Immunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data
por: Vanobberghen, Fiona M, et al.
Publicado: (2015)

Association of First-Line and Second-Line Antiretroviral Therapy Adherence
por: Ramadhani, Habib O., et al.
Publicado: (2014)

Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India
por: Gill, Naresh, et al.
Publicado: (2019)

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
por: Melisi, Davide, et al.
Publicado: (2018)

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017)

Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study
por: Rizzo, Alessandro, et al.
Publicado: (2022)

New Poverty Line and Growth Chart Bring Forth Sharp Inequalities in the Indian Population
por: Bhasin, Sanjiv Kumar
Publicado: (2009)

Associations Between Cessation of Second-Line Therapies and Relapse Rates of Childhood Refractory Minimal-Change Nephrotic Syndrome: A Single-Center, Retrospective Chart Review
por: Jin, Jing, et al.
Publicado: (2022)

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements
por: Bekaii-Saab, Tanios S, et al.
Publicado: (2020)

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe
por: Becker, Jürgen C., et al.
Publicado: (2017)

Second-line treatment for renal cell cancer
por: Di Lorenzo, G, et al.
Publicado: (2012)

Response to second line antiretroviral therapy in India
por: Singh, Anup, et al.
Publicado: (2012)

Second-line treatment options in hepatocellular carcinoma
por: Marino, Donatella, et al.
Publicado: (2019)

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
por: Khan, Samsuddin, et al.
Publicado: (2014)

Establishment of a first-line second-line treatment model for human pulmonary adenocarcinoma
por: Wang, Lining, et al.
Publicado: (2016)

Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines
por: Prager, Welf
Publicado: (2013)

Learning from the past to design better trials in second-line treatment for mesothelioma patients
por: Addeo, Alfredo, et al.
Publicado: (2018)

Second-line therapy for disseminated small-cell lung cancer: optimal management remains to be defined
por: Chouaïd, Christos, et al.
Publicado: (2020)

Optimal first-line and second-line treatments for metastatic renal cell carcinoma: current evidence
por: Sun, Maxine, et al.
Publicado: (2014)

Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
por: Hua, Jie, et al.
Publicado: (2018)

Internal endoscopic drainage as first line or second line treatment in case of postsleeve gastrectomy fistulas
por: Gonzalez, J. M., et al.
Publicado: (2018)

Overview of First-Line and Second-Line Pharmacotherapies for Osteoarthritis with Special Focus on Intra-Articular Treatment
por: Nowaczyk, Alicja, et al.
Publicado: (2022)

Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial
por: Taïeb, Julien, et al.
Publicado: (2023)

Quality of caesarean delivery services and documentation in first-line referral facilities in Afghanistan: a chart review
por: Kim, Young-Mi, et al.
Publicado: (2012)

Which second line treatments after ESA failure?
por: Park, Sophie, et al.
Publicado: (2017)

Cholangiocarcinoma: the quest for a second-line systemic treatment
por: Vienot, Angélique, et al.
Publicado: (2019)

Sirolimus as a second-line treatment for Graves’ orbitopathy
por: Lanzolla, G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1jpd3knumqcfevi6u21skubq60